Crizotinib API Manufacturer in India – Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children. Here in my blog, I am discussing some of the Best Crizotinib API Manufacturer in India.
On August 26, 2011, the U.S. Food and Drug Administration approved crizotinib (Xalkori) to treat certain late-stage (locally advanced or metastatic) non-small cell lung cancers that express the abnormal anaplastic lymphoma kinase (ALK) gene. Crizotinib is generic for the trade chemotherapy drug Xalkori. In some cases, health care professionals may use the trade name Xalkori when referring to the generic drug name crizotinib. The Cancer API Market globally has been developing at an exponentially rapid pace due to factors such as clinical value and efficacy.
The market is expected to develop at a progressive CAGR while earning a high level of revenue in the forecast period. Several factors have been identified that are currently influencing the growth of the market. These include the growing demand for small molecule drugs, increased trends of offshore manufacturing of pharmaceutical products, increased prevalence of cancer and arrival of new active pharmaceutical ingredients (API). Moreover, the inception of smart healthcare is paving the way for new APIs including cancer APIs.
List of Some Crizotinib API Manufacturers in India
The Crizotinib API market is a vast market with numerous major market competitors functioning in many regions of the world. These competitors have come up with advanced drugs that are being used as a first-line and second-line therapy in the treatment of numerous types of cancers.
Check the list mentioned in the blog regarding Crizotinib API Manufacturer in India.
1. RXN Chemicals Pvt. Ltd.:
The company established in the year 2009 at Navi Mumbai (Maharashtra, India). The company is a research-driven company, which specializes in manufacture and distribution of active pharmaceutical ingredient (API) including Crizotinib, pharmaceutical impurity standard, pharmacopeial & non-pharmacopeial reference standards, drug glucosides, drug metabolites, and Isotope labeled reference standards. They undertake custom synthesis from small to bulk scale (mg to kg) synthesis of Crizotinib.
Their client base is spread across the world, most of them being major Pharmaceutical Companies and Natural Products manufacturers to whom they supply Crizotinib and other products as per IP / BP / EP / USP grade with certification and characterization data. The company is are one of the foremost and highly reputed Crizotinib API Manufacturer in India. Their main aim is to provide organic synthesis services that are of world-class quality and at the same time provide value for money too.
Crizotinib which they manufacture is mainly using as Tyrosine Kinase Inhibitor.
Contact them – Unit J 607, Mega Centre, Survey No 151, Magarpatta Hadapsar, Pune, India 411028.
2. Reva Pharma:
Reva Pharma is one of the leading Healthcare and Pharmaceutical organization. Licensing, Product Development, Contract Manufacturing, and Healthcare Services form the main activities of the company. Its operations and initiatives are backed up by regulatory approved infrastructure, which helps to offer its partners, Products & Services complying with cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space across geographies for Reliability, Transparency, and Trust.
REVA operates according to current Good Manufacturing and Laboratory Practice (cGMP and GLP). Their API and FDF manufacturing facilities have received regulatory approval from the following major health authorities. Their R&D strengths are in developing intellectual property in the area of non-infringing processes and resolving complex chemistry challenges.
In the process, they are applying new technology for novel and better processes. The company is a long term commitment to developing innovative technologies and creating a knowledge base in chemical synthesis.
Contact them – 902, Surya Kiran Building, 19 Kasturba Gandhi Marg, New Delhi – 110001, INDIA
3. Laurus Labs:
Laurus Labs is one of the leading Crizotinib API Manufacturer in India. The company is led by an experienced team of executives who bring a deep understanding of the global pharmaceutical industry. They have proven abilities in delivering industry-leading growth and operational performance. Their executive team articulates a clear strategy for Laurus and helps us institutionalize world-class processes across the company.
The company develops Crizotinib that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. They work with 9 of the world’s top 10 generic pharmaceutical companies in the world. They sell Crizotinib in 56 countries. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. As a company, they conduct their business with the utmost transparency and integrity. This helps them attract the best talent and win the trust of their stakeholders.
Contact them – Plot No:21, JN Pharma City, Parawada, Visakhapatnam 531021, Andhra Pradesh, India
4. Shilpa Medicare Ltd:
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML start in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API especially Crizotinib and Formulation globally in different regulated markets. The Research & Development activities at Shilpa Medicare are designed to be carried out in full compliance to sound Intellectual Property principles in vogue. Crizotinib
Raichur Unit I is an API facility catering to Oncology/Non-Oncology APIs especially Crizotinib and CRAMS functions. It has world-class six manufacturing blocks ( Oncology -03 and Non-Oncology -03) competence for gram-to-kilo scale synthesis. The total Non-Oncology products manufacturing reactor volume is 38000L and Oncology products manufacturing reactor volume is 28000L. This state-of-art manufacturing facility has approval certificates from the following regulators: USFDA, EUGMP, TGA, PMDA, and KFDA
Contact them – #12-6-214/A1, Hyderabad Road, Raichur – 584 135, Karnataka, India.
We believe that the information about List of Crizotinib API Manufacturer in India contained in my report is useful for you in either way. So go ahead and choose accordingly by reading the details about the listed Crizotinib API Manufacturer in India. For more, you can also visit our official website. You can also fill the contact form or call us. We always seek the opportunity to help you.